Data. by Su Hwan Park (15158181)

“…Participants in the progression group were younger (60.7 vs. 65.7 years, P = 0.015) and showed a larger BCVA change (0.20 vs. 0.04, P < 0.001) and greater ERM area decrease (34.2% vs. 11.7%, P < 0.001) during the follow-up period. …”

Baseline characteristics of patients. by Su Hwan Park (15158181)

“…Participants in the progression group were younger (60.7 vs. 65.7 years, P = 0.015) and showed a larger BCVA change (0.20 vs. 0.04, P < 0.001) and greater ERM area decrease (34.2% vs. 11.7%, P < 0.001) during the follow-up period. …”

Survey-weighted association of flavonoids and six subclasses intake with MASLD. by Yuwei He (1565941)

Subjects:

Survey-weighted baseline characteristic of the study population by MASLD. by Yuwei He (1565941)

Subjects:

Weighted Quantile Sum model regression index weights for the MASLD. by Yuwei He (1565941)

Subjects:

The flowchart of the sample selection from NHANES 2007-2010, 2017-2018. by Yuwei He (1565941)

Subjects:

Association between flavonoid intakes and metabolic dysfunction-associated steatotic liver disease (MASLD) using a Restricted Cubic Spline regression model, adjusted for age, sex,... by Yuwei He (1565941)

Subjects:

Changes in average income reduction rate of households over time across different income groups. by Na Chen (153323)

Changes in total spillage during the second stage (in-epidemic). by Cuicui Liu (1496260)

Seasonal spatial-temporal trend of NDVI of burned forested areas in Africa (2001–2020). by Oswaldo Maillard (20660661)

Seasonal spatial-temporal trend of NDVI of burned forested areas in Africa (2001–2020) for the two hemispheres. by Oswaldo Maillard (20660661)

Seasonal spatial-temporal trend of NDVI in burned areas across Africa (2001–2020). by Oswaldo Maillard (20660661)

Seasonal spatial-temporal trend of NDVI of burned forested areas in Africa (2001–2020) by countries and territories. by Oswaldo Maillard (20660661)

Seasonal spatial-temporal trends of NDVI in burned areas across Africa, by countries and territories (2001–2020). by Oswaldo Maillard (20660661)

Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

Influencing factors of APCA. by Wenping Ning (19871091)

Subjects:

Temporal trends in APCA. by Wenping Ning (19871091)

Subjects:

Traditional Markov transfer probability matrices. by Wenping Ning (19871091)

Subjects:

Spatial Markov transfer probability matrix. by Wenping Ning (19871091)

Subjects: